SCHEMBL2095023

SCHEMBL2095023

c1cc(CNC2CC[N]C2)cc(-c2ccncc2)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 4/20 0.54
PRKCI P41743 1/20 0.47
CARM1 Q86X55 2/20 0.44
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
HTR5A P47898 1/20 0.42
PARP1 P09874 3/20 0.39
HRH3 Q9Y5N1 1/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
EPHX2 P34913 1/20 0.39
MAP4K4 O95819 2/20 0.38
KCNH2 Q12809 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
AURKA O14965 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14202576 0.82 PRMT6 (0.57) PRMT6PRKCICARM1KDM1AMAOA
SCHEMBL12693730 0.80 PRMT6 (0.55) PRMT6PRKCICARM1KDM1AMAOA
SCHEMBL14204501 0.79 PRMT6 (0.54) PRMT6PRKCICARM1KDM1AMAOA
SCHEMBL3225440 0.78 PRMT6 (0.56) PRMT6PRKCICARM1KDM1AMAOA
SCHEMBL2097947 0.78 ALDH1A1 (0.40) PRMT6PARP1HRH3ALDH1A1KDM4E
SCHEMBL2092274 0.78 CYP1A2 (0.46) KMT2AALDH1A1KDM4EPKM
SCHEMBL3236780 0.77 PRMT6 (0.51) PRMT6PRKCICARM1KDM1AMAOA
SCHEMBL2092320 0.77 GRIN2B (0.54) PRMT6CARM1MEN1RAB9AKMT2A
SCHEMBL2092847 0.76 ALDH1A1 (0.66) KDM1AMAOAALDH1A1KDM4EPKM
SCHEMBL2096817 0.75 ALDH1A1 (0.68) KDM1AMAOAALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631570-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS Abbott Laboratories (US) 2006-03-08 EP claimed
WO-2004083207-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS ABBOTT LABORATORIES (US) 2004-09-30 WO claimed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US claimed
US-8163769-B2 1,8-naphthyridine derivatives ABBOTT LABORATORIES (US) 2012-04-24 US disclosed
EP-1631570-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS Abbott Laboratories (US) 2006-03-08 EP disclosed
WO-2004083207-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS ABBOTT LABORATORIES (US) 2004-09-30 WO disclosed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232818-A1 Antibacterial compounds PGLS, UGT1A1, CASP1 PRMT6 4276/4885PRKCI 4355/4885CARM1 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.